808: The PI3K/mTOR inhibitor NVP-BEZ235 is able to revert selumetinib resistance in colorectal cancer cellular models

Saved in:

Bibliographic Details
Published in	European journal of cancer (1990) Vol. 50; p. S195
Main Authors	Martinez-Lacaci, I, Carballo-Santana, M, Tristante, E, Mayor-López, L, Grasso, S, Carbonell, P, De Torre, C, Luján, J, Alonso, J.L, Carballo, F
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.07.2014
Subjects	Hematology, Oncology and Palliative Medicine
Online Access	Get full text

Loading…

More Information
ISSN:	0959-8049 1879-0852
DOI:	10.1016/S0959-8049(14)50713-7